Monthly Archives: June 2012



 

Two companies have joined forces to develop disease modifying treatments for autism spectrum disorders and Fragile X syndrome. Swiss pharmaceutical company Roche and Seaside Therapeutics based in Cambridge, Massachusetts in the US are hoping that the drug once developed will … Continue reading


»Read More

newsletter signup